3 Top Undervalued Small Caps With Recent Insider Activity

In This Article:

In a week marked by mixed performances in major indices and subdued trading ahead of the holiday weekend, value stocks have notably outperformed growth shares. Amid these market dynamics, small-cap stocks present intriguing opportunities for investors, particularly those with recent insider activity signaling potential undervaluation. Identifying a good stock often involves looking at factors such as strong fundamentals, positive insider activity, and alignment with current economic indicators. In this context, let's explore three top undervalued small-cap stocks that have recently caught the attention of insiders.

Top 10 Undervalued Small Caps With Insider Buying

Name

PE

PS

Discount to Fair Value

Value Rating

Bytes Technology Group

23.4x

5.3x

17.09%

★★★★★☆

Nexus Industrial REIT

3.6x

3.6x

23.11%

★★★★★☆

PCB Bancorp

11.1x

2.8x

42.92%

★★★★★☆

Hemisphere Energy

5.7x

2.2x

14.87%

★★★★☆☆

Citizens & Northern

12.8x

2.9x

43.63%

★★★★☆☆

Franklin Financial Services

10.4x

2.1x

36.56%

★★★★☆☆

Sagicor Financial

1.3x

0.3x

-41.33%

★★★★☆☆

CVS Group

22.7x

1.2x

40.45%

★★★★☆☆

MYR Group

30.4x

0.4x

49.12%

★★★☆☆☆

Community West Bancshares

18.7x

2.9x

42.25%

★★★☆☆☆

Click here to see the full list of 194 stocks from our Undervalued Small Caps With Insider Buying screener.

Let's dive into some prime choices out of from the screener.

Assura

Simply Wall St Value Rating: ★★★★☆☆

Overview: Assura is a UK-based real estate investment trust specializing in the development and management of primary care properties, with a market cap of approximately £2.20 billion.

Operations: Assura generates revenue primarily from its core segment, with the latest reported figure being £157.8 million. The company's gross profit margin has shown a slight decline from 95.75% in Q3 2016 to 90.81% in Q1 2024. Operating expenses and non-operating expenses have significantly impacted net income margins, which have varied widely over recent periods, reaching as high as 113.88% in Q1 2022 and falling to -110.03% in Q3 2023 due to substantial non-operating costs.

PE: -45.5x

Assura, a healthcare real estate investment trust, recently announced a 0.84 pence per share dividend payable on October 9, 2024. They acquired a private hospital portfolio in August 2024, expanding their asset base. Despite relying solely on external borrowing for funding, Assura's debt is well-covered by operating cash flow. Earnings are forecast to grow annually by 41.82%. Insider confidence is evident with recent share purchases from July to September 2024, suggesting optimism about future prospects for this small-cap stock.